Page last updated: 2024-11-12

11 beta-hydroxyandrosterone

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

11 beta-hydroxyandrosterone: RN given refers to (3alpha,5alpha,11beta)-isomer; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID10286365
CHEMBL ID1908033
CHEBI ID34350
SCHEMBL ID3362889
MeSH IDM0043165

Synonyms (42)

Synonym
57-61-4
nsc-56288
3alpha,11beta-dihydroxy-5alpha-androstane-17-one
11beta-hydroxyandrosterone
11-hydroxyetiocholanolone
LMST02020086
11-hydroxyandrosterone
3,11-dihydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,14,15,16-tetradecahydrocyclopenta[a]phenanthren-17-one
(3r,5s,8s,9s,10s,11s,13s,14s)-3,11-dihydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,14,15,16-tetradecahydrocyclopenta[a]phenanthren-17-one
nsc 56288
androstan-17-one, 3,11-dihydroxy-, (3alpha,5alpha,11beta)-
0jyd539gc3 ,
unii-0jyd539gc3
chebi:34350 ,
CHEMBL1908033
11-oxyetiocholanolone
5.alpha.-androstan-17-one, 3.alpha.,11.beta.-dihydroxy-
ba-2685
11.beta.-hydroxyandrosterone
androstan-17-one, 3,11-dihydroxy-, (3.alpha.,5.alpha.,11.beta.)-
3.alpha.,11.beta.-dihydroxy-5.alpha.-androstane-17-one
3.alpha.,11.beta.-dihydroxy-5.alpha.-androstan-17-one
11.beta.-oh-androsterone
5.alpha.-androstane-3.alpha.,11.beta.-diol-17-one
SCHEMBL3362889
11-beta-hydroxyandrosterone
3,11-dihydroxyandrostan-17-one #
5.alpha.-androstan-3.alpha.,11.beta.-diol-17-one
PIXFHVWJOVNKQK-PTXZMSDUSA-N
11-.beta.-hydroxyandrosterone
11-|a inverted exclamation mark-hydroxyandrosterone
11beta-hydroxy-androsterone
11-hydroxy-androsterone
3alpha,11beta-dihydroxy-5alpha-androstan-17-one
5alpha-androstan-3alpha,11beta-diol-17-one
Q27116006
DTXSID301018932
11 beta-hydroxyandrosterone
MS-24441
11|a-hydroxyandrosterone
CS-0062274
HY-113351

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" While testosterone treatment at physiological doses resulted in stimulation of GtH-II-alpha and -beta subunit mRNA production, time-course and dose-response studies performed on sexually immature goldfish of mixed sex, using a wider dose range exceeding physiological levels, demonstrated a biphasic response to in vivo androgen treatment."( Effect of testosterone on maturational gonadotropin subunit messenger ribonucleic acid levels in the goldfish pituitary.
Habibi, HR; Huggard, D; Kassam, G; Khakoo, Z; Mahmoud, SS, 1996
)
0.29
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
androgenA sex hormone that stimulates or controls the development and maintenance of masculine characteristics in vertebrates by binding to androgen receptors.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
3-hydroxy steroidAny hydroxy steroid carrying a hydroxy group at position 3.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (1)

PathwayProteinsCompounds
Glucocorticoid biosynthesis1411

Bioassays (3)

Assay IDTitleYearJournalArticle
AID624618Specific activity of expressed human recombinant UGT2B42000Annual review of pharmacology and toxicology, , Volume: 40Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
AID624616Specific activity of expressed human recombinant UGT2B152000Annual review of pharmacology and toxicology, , Volume: 40Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
AID624619Specific activity of expressed human recombinant UGT2B72000Annual review of pharmacology and toxicology, , Volume: 40Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (26)

TimeframeStudies, This Drug (%)All Drugs %
pre-199013 (50.00)18.7374
1990's2 (7.69)18.2507
2000's4 (15.38)29.6817
2010's7 (26.92)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.40

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.40 (24.57)
Research Supply Index3.30 (2.92)
Research Growth Index4.70 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.40)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews2 (7.69%)6.00%
Case Studies2 (7.69%)4.05%
Observational0 (0.00%)0.25%
Other22 (84.62%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]